TPOXX® Antiviral Treatment (Tecovirimat)
Details
- Supplier(s)
- Meridian Medical Technologies Ltd
- Value
- GBP 1
- Topic
- Antivirals for systemic use
- Published
- 3 November 2022
- Source
- uk:find_a_tender
Tender description
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK. Lot 1: Supply of Tecovirimat antiviral treatment
Timeline
- Completed: Award date28 July 2022
- Completed: Award published3 November 2022Current notice
About the buyer
UK Health Security Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33651400 · Antivirals for systemic use
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov |
Related buyers
Buyers similar to UK Health Security Agency.
- 2,599£1.6bn
- 882£19.4bn
- 678£8.8bn
- 426£3.8bn
- 341£20.3m
- 294£367.0m
- 257£233.4m
- 247£577.4m
- 232£10.1bn
- 169£47.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
